| Non-Small Cell Lung Cancer |
1 |
1 |
| Lung Cancer |
0 |
0.9 |
| Small Cell Lung Cancer |
0 |
0.73 |
| Cancer |
0 |
0.66 |
| Squamous Cell Carcinoma |
0 |
0.54 |
| Biologic Therapy |
0 |
0.53 |
| Targeted Cancer Therapy |
0 |
0.5 |
| Lung |
0 |
0.44 |
| Toxicology |
0 |
0.37 |
| Europe |
0 |
0.33 |
| Tumor |
0 |
0.33 |
| Liver Tumor |
0 |
0.32 |
| Anaplastic Lymphoma Kinase |
0 |
0.27 |
| Aminotransferase |
0 |
0.23 |
| Tyrosine Kinase Inhibitor |
0 |
0.23 |
| Histology |
0 |
0.22 |
| Liver |
0 |
0.22 |
| Tyrosine Kinase |
0 |
0.22 |
| Peripheral Edema |
0 |
0.15 |
| White Blood Cell Count |
0 |
0.15 |
| Adenocarcinoma |
0 |
0.11 |
| Blood |
0 |
0.11 |
| Chemotherapy |
0 |
0.11 |
| Edema |
0 |
0.11 |
| Hospital |
0 |
0.11 |
| Platelet Count |
0 |
0.11 |
| Platinum |
0 |
0.11 |
| Receptors |
0 |
0.11 |